MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression
2016 · Oncogenesis · 91 citations
https://doi.org/10.1038/oncsis.2016.1
X
Xiang Yan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
238
Papers
4.7K
Citations
29
h-index
75
i10-index
Xiang Yan is an academic researcher from Guangzhou University of Chinese Medicine. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Diabetes and associated disorders & Lung Cancer Treatments and Mutations. The author has an h-index of 29, co-authored 203 publications.
ORCID: 0000-0002-3683-474XPapers by this author
worksImpact of the combined timing of PD-1/PD-L1 inhibitors and chemotherapy on the outcomes in patients with refractory lung cancer
2021 · ESMO Open · 24 citations
https://doi.org/10.1016/j.esmoop.2021.100094
Afatinib and Dacomitinib Efficacy, Safety, Progression Patterns, and Resistance Mechanisms in Patients with Non-Small Cell Lung Cancer Carrying Uncommon EGFR Mutations: A Comparative Cohort Study in China (AFANDA Study)
2022 · Cancers · 19 citations
https://doi.org/10.3390/cancers14215307
Dacomitinib for Advanced Non-small Cell Lung Cancer Patients Harboring Major Uncommon EGFR Alterations: A Dual-Center, Single-Arm, Ambispective Cohort Study in China
2022 · Frontiers in Pharmacology · 15 citations
https://doi.org/10.3389/fphar.2022.919652
Noninvasive early identification of durable clinical benefit from immune checkpoint inhibition: a prospective multicenter study (NCT04566432)
2024 · Signal Transduction and Targeted Therapy · 15 citations
https://doi.org/10.1038/s41392-024-02060-3
Short-read and long-read full-length transcriptome of mouse neural stem cells across neurodevelopmental stages
2022 · Scientific Data · 12 citations
https://doi.org/10.1038/s41597-022-01165-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat